Stada, buyout funds in race for Bristol-Myers' French business, say sources: Reuters

German generic drugmaker Stada (STAGn.DE) is vying with a group of European buyout funds for control of Bristol-Myers Squibb’s (BMY.N) French over-the-counter drugs business, sources told Reuters.